Cannabis for Alzheimer's Disease

Studies and Information on Cannabis for Alzheimer's Disease

Alzheimer’s disease (AD), a chronic degenerative illness that affects the mind and brain, is partially characterized by selective neuronal loss (AD kills brain cells) and cognitive deficits.

Generally speaking, scientists believe that AD originates in part from genetic, environmental, and lifestyle causes. Established risk factors include lack of exercise, obesity, hypertension, diabetes, depression, and smoking. More specifically, one hypothesis proposes beta-amyloid plaque as a factor, partially due to doctors observing higher concentrations in the brain cells of Alzheimer patients.

Another discovery in AD involves a protein called tau, which in AD tangles and twists, preventing the delivery of nutrients to brain cells. Scientists believe that these plaques and tangles induce neuro-chemical and inflammatory changes responsible for the development of the disease.

Ratings for Cannabis and Alzheimer's Disease

Rated 2.4 / 5 (How Ratings Work)

Possible to probable range of efficacy of cannabis for treatment of alzheimer's disease.
Based on 28 Studies from 1997 - 2017

Studies on Cannabis and Alzheimer's Disease

Study Name, Description & Year


Delta-9-tetrahydrocannabinol For Nighttime Agitation In Severe Dementia
A human trial conducted on six patients with dementia (5 with Alzheimer's and one with vascular dementia). — 2006


Effects Of Dronabinol On Anorexia And Disturbed Behavior In Patients With Alzheimer's Disease
A placebo-controlled crossover design conducted on 15 patients with probable Alzheimer's disease. — 1997